Human Papillomavirus-Related Head and Neck Mucosal Squamous Cell Carcinoma

Human Papillomavirus-Related Head and Neck Mucosal Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

55 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 31
Recruiting: 16
Ph III recruiting: 0
Growth YoY: —
Industry share: 19%
Top sponsor: Abramson Cancer Center at Penn Medicine
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07578467	Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+ OPSCCs	not yet recruiting	Phase 1 / Phase 2	35	Abramson Cancer Center at Penn MedicineOTHER	0	Jul 8, 2026	clinicaltrials
NCT05582590	Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers	not yet recruiting	Phase 1	36	NexImmune Inc.INDUSTRY	0	Jan 16, 2024	clinicaltrials